VanEck’s €7.4bn Dividend Fund Gets an Irish Sibling to Bypass a Structural Quirk

VanEck's new TDVX ETF excludes US stocks and offers automatic dividend reinvestment, addressing a key limitation of its €7.4bn parent fund TDIV.

A structural detail baked into Europe’s largest dividend ETF at its launch a decade ago has forced its issuer to create a companion fund. The move opens up a new option for income investors who want automatic reinvestment — something the original vehicle simply cannot offer.

VanEck listed the Morningstar Developed Markets ex-US Dividend Leaders UCITS ETF (TDVX) on the London Stock Exchange on 23 April. The new fund follows the same index methodology as the flagship VanEck Morningstar Developed Markets Dividend Leaders (TDIV), but with one critical difference: it excludes US stocks entirely. More importantly, it is domiciled in Ireland, a jurisdiction that allows for accumulating share classes.

The parent fund, TDIV, was set up in the Netherlands in 2016. That structure gave Dutch investors a tax advantage on withholding tax reclaims, but it has blocked the introduction of a reinvesting share class — a feature that has grown in demand as yield-seeking investors look for compounding without manual intervention. VanEck product manager Dmitrii Ponomarev confirmed that relocating TDIV to Ireland was ruled out to avoid confusing existing holders. Instead, the issuer opted for a clean-sheet launch.

The timing is no coincidence. Dividend funds worldwide pulled in roughly $24bn in the first quarter of 2026, the strongest start to a year in four years. Investors are chasing tangible returns as US mega-cap tech groups plough cash into artificial intelligence rather than buybacks or dividends. At the same time, international equities have lagged the US market, making a fund that deliberately excludes American stocks a timely bet.

TDIV itself remains a heavyweight. It manages around €7.4bn in assets and trades at €52.35, just shy of its 52-week high of €52.86. The fund has gained roughly 8% since the start of the year and sits about 25% above the trough it hit in June 2025. Its dividend yield stands at 3.83%.

The portfolio holds exactly 100 stocks drawn from 20 developed markets. Selection is rigorous: companies must have raised their dividend per share over the past five years and must keep their payout ratio below 75% of earnings. Morningstar also screens out firms with severe sustainability risks. The aim is to ensure that the yield comes from genuine profit growth rather than a collapsing share price. Pfizer, which recently confirmed a quarterly dividend of $0.43 per share, is a textbook example of the kind of steady payer the index targets.

Sector weights are capped at 40%. Financials lead at 31.6%, followed by energy at 17.9% and healthcare at 15.3%. Top holdings include Exxon Mobil, Verizon, Pfizer, Roche and Nestlé.

TDIV paid out a total of $1.98 per share in 2025, up from $1.814 the year before. That works out to average dividend growth of roughly 17% over three years. The most recent quarterly distribution of €0.21 per share was made in March 2026. The next payout is expected in June, with the fund going ex-dividend on 4 June and the cash landing in accounts on 11 June.

That same month brings the index’s semi-annual review, when underperformers are culled and the portfolio is refreshed for the summer. For income investors weighing the old fund against the new, the choice is now clear: TDIV for regular payouts, TDVX for automatic reinvestment and a more tax-efficient wrapper for international holdings.